06:26 AM EST, 02/10/2025 (MT Newswires) -- Oncolytics Biotech ( ONCY ) , a clinical-stage company specializing in immunotherapy for oncology, late on Friday said Matt Coffey is stepping down as chief executive and director.

Coffey will not return to his role following a medical leave of absence and ongoing health concerns.

The company will initiate a search for Coffey's successor and Wayne Pisano will remain as interim CEO until a new CEO is hired.